The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy toxicity prediction in patients with melanoma using machine learning algorithms.
 
Lakshya Sharma
No Relationships to Disclose
 
Esha Mohan
No Relationships to Disclose
 
Vaishnavi Balaji
Employment - Curenetics
 
Jonathan Wong
Employment - Curenetics
 
Adwait Joshi
No Relationships to Disclose
 
Iosif Mporas
No Relationships to Disclose
 
Jiaqi Shi
No Relationships to Disclose
 
Yi Zhao
No Relationships to Disclose
 
Amy C. Stoll-D'Astice
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb/Celgene (I); Cigna (I); Gilead Sciences (I); Lilly (I); Lucid Diagnostics (I); Moderna Therapeutics; Novo Nordisk; Regeneron
Consulting or Advisory Role - Curenetics; Grace Science
 
Vipula Tailor
Stock and Other Ownership Interests - CurenX
 
Georgie Powell
Employment - Curenetics
 
Doraid Alrifai
No Relationships to Disclose
 
Riyaz N.H. Shah
Honoraria - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); EQRx (Inst); Guardant Health (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
(OPTIONAL) Uncompensated Relationships - ALK; British Thoracic Oncology Group; EGFR Positive UK; Roy Castle Lung Cancer Foundation
 
Justin S. Waters
No Relationships to Disclose
 
Sola Michael Adeleke
Stock and Other Ownership Interests - Curenetics; CurenX